28 note to investors, William Blair analysts wrote that Applied Therapeutics suspects the CRL was related to the efficacy package as opposed to [chemistry, manufacturing and controls] or safety. Results from the Phase III ACTION-Galactosemia Kids study, unveiled in April 2023, showed that govorestat fell short of its primary efficacy endpoint, a composite of four clinical measures designed to assess various domains of galactosemia symptoms
Milk and Dairy Products: Contain moderate amounts
These supplements contain no artificial colors, sweeteners, or preservatives and many of the formulations contain no sugar, salt, milk, gluten, wheat, yeast, or shellfish, so this line of products is suitable for most people with dietary restrictions and various types of allergies.
Ueda P, Wintzell V, Melbye M, Eliasson B, Soderling J, Gudbjornsdottir S, et al
Document Your Experience